Abstract
Bacterial melanin (BM) has been used in different series of experiments as a neuroprotector. It facilitates recovery and regeneration processes after CNS lesions. The action of BM after Substantia Nigra destruction is of major interest. Electrophysiological study tries to reveal the effects of this substance on the electrical activity of Substantia Nigra pars compacta (SNc) neurons. The substance significantly increases the firing rate of SNc dopaminergic neurons. BM increases the rate of excitatory responses after high frequency tetanic stimulation of ipsilateral caudate–putamen. Overall increase in firing rate of SN neurons can contribute to recovery processes after neuronal degeneration in SN.
References
Aghajanyan AE, Hambardzumyan AA, Hovsepyan AS, Asaturian RA, Vardanyan AA, Saghiyan AA (2005) Isolation, purification and physicochemical characterization of water-soluble Bacillus thuringiensis melanin. Pigment Cell Res 18(2):130–135
Azaryan KG, Petrosyan MT, Popov YG, Martirosyan GS (2004) Melanin in the agriculture and dendrology. Bull Armen Agric Acad 4:7–10
Berliner DL, Erwin RL, McGee DR (1993) Methods of treating Parkinson’s disease using melanin. US Patent 5,210,076 A
Blythe SN, Atherton JF, Bevan MD (2007) Synaptic activation of dendritic AMPA and NMDA receptors generates transient high-frequency firing in substantia nigra dopamine neurons in vitro. J Neurophysiol 97(4):2837–2850
Fanardzhyan VV (2001) The functional role of the red nucleus in the cerebral cortex cerebellum–spinal cord communicating system. Usp Fiziol Nauk 32(2):3–15
Fasano M, Bergamasko B, Lopiano L (2006) Modifications of the iron neuromelanin system in Parkinson’s disease. J Neurochem 96:909–916
Faucheux BA, Maгtin ME, Beaumont CM, Hauw JJ, Agid V, Hiгsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson’s disease. J. Neuгochem 86(5):1142–1148
Gevorkyan OV, Meliksetyan IB, Hovsepyan AS, Sagiyan AS (2007) Effects of BT-melanin on recovery of operant conditioned reflexes in rats after ablation of the sensorimotor cortex. Neurosci Behav Physiol 37(5):471–476
Lacey MG, Mercuri NB, North RA (1990) Actions of cocaine on rat dopaminergic neurones in vitro. Br J Pharmacol 99(4):731–735
Lee CR, Abercrombie ED, Tepper JM (2004) Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels. Neuroscience 129:481–489
Heida T, Stegenga J, Lourens, MAJ, Meijer HGE, van Gils SA, Lazarov N, Marani E (2012) Simulating idiopathic Parkinson’s disease by in vitro and computational models. In: Naik GR (ed) Applied biological engineering—principles and practice. Intech, Croatia, pp 209–236
Manivasagan P, Venkatesan J, Sivakumar K, Kim S-K (2013) Actinobacterial melanins: current status and perspective for the future. World J Microbiol Biotechnol. doi:10.1007/s11274-013-1352-y
Mann DM, Yates PO, Marcyniuk B (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer’s disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev 25(1–2):189–204
Paxinos O, Watson C (2005) The rat brain in stereotaxic coordinates. Academic, Burlington, p 367
Petrosyan TR, Gevorkyan OV, Meliksetyan IB, Hovsepyan AS, Manvelyan LR (2012) The action of bacterial melanin in rats after pyramidal tract lesions. J Pathophysiol Elsevier 19:P71–P80
Popov JG (2003) Proceedings of II Moscow International Congress of Biotechnology: a status and prospects of development. Part I, Moscow, pp 222–223
Proctor PH (1989) Free radicals and human disease. In: CRC Handbook of Free Radicals and Antioxidants, vol 1, no 1989, pp 209–221
Proctor PH, Reynolds ES (1984) Free radicals and disease in man. Physiol Chem Phys Med NMR 16(3):175–195
Sarkissian JS, Galoyan AA, Kamalyan RG, Chavushyan VA, Meliksetyan IB, Poghosyan MV, Gevorkyan OV, Hovsepyan AS, Avakyan ZE, Kazaryan SA, Manucharyan MK (2007) The effect of bacterial melanin on electrical activity of neurons of the substantia nigra under conditions of GABA generation. Neurochem J 1(3):227–234
Sarna T (1992) Properties and function of the ocular melanin—a photobiophysical view. J Photochem Photobiol 12:215–258
Solis A, Lara ME, Rendon LE (2007) Photoelectrochemical properties of melanin. Nat Preced hdl:10101/npre., Nov. 1312.1
Zecca L (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson’s disease. FEBS Lett 16:216–220
Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D (2001) Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J Clin Pathol Mol Pathol 54:414–418
Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R (2008) Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease. Acta Neuropathol 116:47–55
Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca F, Faust R, Qian S, Miller D (2011) Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson’s disease. Neurotox Res 19:68–72
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petrosyan, T.R., Chavushyan, V.A. & Hovsepyan, A.S. Bacterial melanin increases electrical activity of neurons in Substantia Nigra pars compacta. J Neural Transm 121, 259–265 (2014). https://doi.org/10.1007/s00702-013-1095-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-013-1095-9